Home Newsfeeds Presto Technologies Q3 EPS $0.71, Sales $7.80M

Presto Technologies Q3 EPS $0.71, Sales $7.80M

Presto Technologies (NASDAQ:PRST) reported quarterly earnings of $0.71 per share. The company reported $7.80 million in sales this quarter.

byBenzinga Newsdesk

November 15, 2022

1 minute read

Presto Technologies (NASDAQ:PRST) reported quarterly earnings of $0.71 per share. The company reported $7.80 million in sales this quarter.

MillerKnoll CEO Tells Employees To ‘Get The Damn $26 Million’ And ‘Leave Pity City,’ Goes Viral

By Chris Katje

April 18, 12:02 PM

Times have been tougher in in the workplace in 2022 and 2023 as companies and the labor force face high inflation, banks failures and job cuts.

MLKN

Nova Lifestyle Q3 Sales $3.00M Up From $2.92M YoY

By Michael Horton

November 18, 5:06 PM

Nova Lifestyle (NASDAQ:NVFY) reported $3.00 million in sales this quarter. This is a 2.85 percent increase over sales of $2.92 million the same period last year.

NVFY

‘Moderna Strikes Deal To Develop mRNA Drugs In China’ – CNBC

By Benzinga Newsdesk

July 5, 9:16 AM

https://www.cnbc.com/2023/07/05/moderna-strikes-deal-to-develop-mrna-drugs-in-china-.htmlModernaon Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in

MRNA

News
Tech

Tim Cook Doesn’t See A Path Back To Chip Vendors: ‘We Like To Own The Primary Technologies In The Products That We Ship’

By Ananya Gairola

November 3, 7:23 AM

Apple CEO Tim Cook emphasizes the company's commitment to in-house silicon development, stating that owning the primary technologies in their products, especially chips, is strategic and beneficial, with no plans to revert to external chip vendors.

AAPL

Presto Technologies Q3 EPS $0.71, Sales $7.80M

Related Posts

MillerKnoll CEO Tells Employees To ‘Get The Damn $26 Million’ And ‘Leave Pity City,’ Goes Viral

Nova Lifestyle Q3 Sales $3.00M Up From $2.92M YoY

‘Moderna Strikes Deal To Develop mRNA Drugs In China’ – CNBC

Tim Cook Doesn’t See A Path Back To Chip Vendors: ‘We Like To Own The Primary Technologies In The Products That We Ship’